{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:37:45Z","timestamp":1789832265634,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["GAP0484"],"award-info":[{"award-number":["GAP0484"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP-2025"],"award-info":[{"award-number":["MLP-2025"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"CSIR - Central Drug Research Institute","doi-asserted-by":"publisher","award":["HCP-40"],"award-info":[{"award-number":["HCP-40"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.056","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T23:51:37Z","timestamp":1767397897000},"page":"2408-2426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery, preclinical safety, and efficacy characterization of SMAC mimetic S-016-1348 as a potential cancer therapeutic"],"prefix":"10.1016","volume":"34","author":[{"given":"Abhipsa","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq Ahmad","family":"Nengroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himangsu Sekhar","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan Kumar","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Katekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Rathaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanti","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjna","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Kumar","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulranjan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravishankar","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Barthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem Narayan","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind Singh","family":"Kshatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Sankar","family":"Ampapathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaur Rahaman","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Koley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahajul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7540-8543","authenticated-orcid":false,"given":"Dipak","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.056_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.056_bib2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/35022514","article-title":"Structural and biochemical basis of apoptotic activation by SMAC\/DIABLO","volume":"406","author":"Chai","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.056_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1126\/science.1207862","article-title":"Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination","volume":"334","author":"Dueber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.056_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(00)00009-X","article-title":"Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins","volume":"102","author":"Verhagen","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.056_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.12.056_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","article-title":"cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination","volume":"30","author":"Bertrand","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.12.056_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030663","article-title":"Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC","volume":"9","author":"Abbas","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.12.056_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2011.06.011","article-title":"cIAPs block Ripoptosome formation, a RIP1\/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms","volume":"43","author":"Feoktistova","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2025.12.056_bib9","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.12.056_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/35065125","article-title":"A conserved XIAP-interaction motif in caspase-9 and SMAC\/DIABLO regulates caspase activity and apoptosis","volume":"410","author":"Srinivasula","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.056_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/35050006","article-title":"Structural basis for binding of SMAC\/DIABLO to the XIAP BIR3 domain","volume":"408","author":"Liu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.056_bib12","doi-asserted-by":"crossref","first-page":"e2073","DOI":"10.1038\/cddis.2015.412","article-title":"X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity","volume":"7","author":"Evans","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.12.056_bib13","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1038\/onc.2008.302","article-title":"IAP-targeted therapies for cancer","volume":"27","author":"LaCasse","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.12.056_bib14","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1038\/onc.2012.265","article-title":"An apoptosis-independent role of SMAC in tumor suppression","volume":"32","author":"Qiu","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.12.056_bib15","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1158\/1078-0432.CCR-19-1430","article-title":"A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma","volume":"26","author":"Mita","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.12.056_bib16","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/bloodadvances.2020003829","article-title":"Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis","volume":"5","author":"Pemmaraju","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.12.056_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/app11010335","article-title":"An Updated Review of SMAC Mimetics, LCL161, Birinapant, and GDC-0152 in Cancer Treatment","volume":"11","author":"Chang","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ymthe.2025.12.056_bib18","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.1073\/pnas.0711122105","article-title":"Both cIAP1 and cIAP2 regulate TNF\u03b1-mediated NF-\u03baB activation","volume":"105","author":"Mahoney","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.056_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.it.2016.06.002","article-title":"More to Life than NF-\u03baB in TNFR1 Signaling","volume":"37","author":"Ting","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2025.12.056_bib20","doi-asserted-by":"crossref","first-page":"e936","DOI":"10.1038\/cddis.2013.457","article-title":"Identification of DR5 as a critical, NF-\u03baB-regulated mediator of SMAC-induced apoptosis","volume":"4","author":"Eckhardt","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.12.056_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI80420","article-title":"Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions","volume":"125","author":"Ashkenazi","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.056_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41419-021-03730-8","article-title":"CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5","volume":"12","author":"Nengroo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.12.056_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102833","article-title":"Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc\u2212) in colorectal cancer","volume":"65","author":"Saini","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2025.12.056_bib24","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1038\/s41467-022-35059-x","article-title":"EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis","volume":"13","author":"Verma","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.056_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2408049121","article-title":"ACSL4-mediated H3K9 and H3K27 hyperacetylation upregulates SNAIL to drive TNBC metastasis","volume":"121","author":"Sinha","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.056_bib26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/35050012","article-title":"Structural basis of IAP recognition by SMAC\/DIABLO","volume":"408","author":"Wu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.056_bib27","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1021\/bi0121454","article-title":"Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners","volume":"41","author":"Kipp","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2025.12.056_bib28","doi-asserted-by":"crossref","first-page":"16686","DOI":"10.1021\/ja047438+","article-title":"Structure-based design of potent, conformationally constrained SMAC mimetics","volume":"126","author":"Sun","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2025.12.056_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jm801101z","article-title":"Design, synthesis, and evaluation of potent, nonpeptidic mimetics of second mitochondria-derived activator of caspases","volume":"52","author":"Sun","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.12.056_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S1470-2045(20)30327-2","article-title":"Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study","volume":"21","author":"Sun","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2025.12.056_bib31","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.orglett.6b00863","article-title":"Diastereoselective Synthesis of 5-Heteroaryl-Substituted Prolines Useful for Controlling Peptide-Bond Geometry","volume":"18","author":"Ali","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ymthe.2025.12.056_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2407-9-125","article-title":"Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma","volume":"9","author":"Augello","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2025.12.056_bib33","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1074\/jbc.M512178200","article-title":"Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprotegerin, BCL-2, and IAP-1","volume":"281","author":"Toruner","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.12.056_bib34","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1038\/sj.onc.1209753","article-title":"Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.12.056_bib35","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/0008-5472.CAN-04-2649","article-title":"Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells","volume":"65","author":"Berezovskaya","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.12.056_bib36","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1038\/sj.onc.1203025","article-title":"Induction of the TRAIL receptor KILLER\/DR5 in p53-dependent apoptosis but not growth arrest","volume":"18","author":"Wu","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.12.056_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1476-4598-9-182","article-title":"NF-\u03baB activation enhances cell death by antimitotic drugs in human prostate cancer cells","volume":"9","author":"Parrondo","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2025.12.056_bib38","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1158\/1078-0432.CCR-10-2262","article-title":"SMAC modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway","volume":"17","author":"Sun","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.12.056_bib39","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/1078-0432.CCR-11-0426","article-title":"Role of SMAC in determining the chemotherapeutic response of esophageal squamous cell carcinoma","volume":"17","author":"Xu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.12.056_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/1535-7163.MCT-10-0643","article-title":"Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.12.056_bib41","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/s41418-020-0541-0","article-title":"Targeting triple-negative breast cancers with the SMAC-mimetic birinapant","volume":"27","author":"Lalaoui","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.12.056_bib42","doi-asserted-by":"crossref","first-page":"45088","DOI":"10.18632\/oncotarget.15125","article-title":"Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells","volume":"8","author":"Panayotopoulou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.12.056_bib43","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1098231","article-title":"A small molecule SMAC mimic potentiates TRAIL- and TNFalpha-mediated cell death","volume":"305","author":"Li","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.056_bib44","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/jm040037k","article-title":"Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer","volume":"47","author":"Oost","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.12.056_bib45","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/lary.25056","article-title":"Combination effects of SMAC mimetic birinapant with TNF\u03b1, TRAIL, and docetaxel in preclinical models of HNSCC","volume":"125","author":"Eytan","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ymthe.2025.12.056_bib46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.omto.2022.11.004","article-title":"The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity","volume":"27","author":"Song","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.12.056_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cgt.2012.83","article-title":"Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-\u03b1 leads to synergistic antitumor activity","volume":"20","author":"Yuan","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.056_bib48","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/1535-7163.MCT-20-1050","article-title":"Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer","volume":"20","author":"Crawford","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.12.056_bib49","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/cbt.20563","article-title":"AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer","volume":"13","author":"Brunckhorst","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.056_bib50","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/1535370216661779","article-title":"The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-\u03b1 and TRAIL-induced apoptosis","volume":"241","author":"El-Mesery","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ymthe.2025.12.056_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fped.2014.00075","article-title":"SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy","volume":"2","author":"Rettinger","year":"2014","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymthe.2025.12.056_bib52","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/JTO.0b013e318226b4a6","article-title":"BV6, an IAP Antagonist, Activates Apoptosis and Enhances Radiosensitization of Non-small Cell Lung Carcinoma In Vitro","volume":"6","author":"Li","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ymthe.2025.12.056_bib53","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1158\/1078-0432.CCR-13-2376","article-title":"Molecular Pathways: Targeting Death Receptors and SMAC Mimetics","volume":"20","author":"Fulda","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.12.056_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14278","article-title":"SMAC mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma","volume":"8","author":"Beug","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.056_bib55","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2025.12.056_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Cancer"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162501130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162501130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:33:55Z","timestamp":1775057635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162501130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S152500162501130X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.056","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery, preclinical safety, and efficacy characterization of SMAC mimetic S-016-1348 as a potential cancer therapeutic","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}